跳至主要内容
临床试验/NCT05724589
NCT05724589已完成不适用

The Effectiveness of Epidermal Growth Factor Serum for the Improvement of Facial Skin Hydration, Elasticity, Pigmentation, and Wrinkles at the Institute of Dermatology: a Single-centered Pilot Study With a One-group Before-and-after Design

Institute of Dermatology, Thailand1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2023年1月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
28
试验地点
1
主要终点
Facial Skin Hydration

研究概览

简要总结

EGF is a polypeptide that promotes cell differentiation and collagen production while decreasing melanin production. This study is designed to study its effectiveness in improving the texture and appearance of facial skin after daily topical application. We hypothesized that EGF would improve facial skin hydration, elasticity, pigmentation, and wrinkles.

详细描述

All patients gave written informed consent for epidermal growth factor serum application on the face. The pilot study enrolls thirty patients compared to pre and post-serum used to evaluate facial skin hydration, transepidermal water loss, elasticity, pigmentation, and wrinkles measured by corneometer, tewameter, cutometer, visioscan, and mexameter respectively on day 0, then 8, 12, and 16 weeks. The study evaluates subject satisfaction and side effects after serum application as secondary outcomes.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Mild to moderate facial skin condition, as measured by 1-2 points on the hyperpigmentation status scale or 2-3 points on the wrinkle severity grading scale.

排除标准

  • Use of lotions or skin care products containing ingredients such as vitamin A/C, hydroquinone, or anti-aging agents.
  • Sunbathing
  • Hypersensitivity to serum components
  • Pregnancy and breast-feeding
  • Active skin diseases such as eczema or atopic dermatitis at the application site

研究组 & 干预措施

Epidermal Growth Factor Serum Application

Experimental

Participants received Epidermal growth factor serum application on the face daily for two months compared to pre and post-results of skin quality.

干预措施: Epidermal Growth Factor (Drug)

结局指标

主要结局

Facial Skin Hydration

时间窗: 4 months (Baseline, Week 8, Week 12, Week 16)

Facial skin hydration was measured using a Corneometer, which provides readings in arbitrary units (a.u.). Measurements were taken at baseline (Day 0), Week 8, Week 12, and Week 16 under standardized environmental and procedural conditions to ensure reliability and accuracy. Higher values indicate better skin hydration, while lower values indicate increased dryness.

Transepidermal Water Loss

时间窗: 4 months

measured by tewameter on day 0, then at 8, 12, and 16 weeks.

Facial Skin Elasticity (R2 Parameter Via Cutometer)

时间窗: Baseline, Week 8, Week 12, Week 16

Skin elasticity was assessed using a Cutometer with the R2 parameter (Ua/Uf), which measures gross elasticity. R2 values range from 0 to 1.0, with higher values indicating better skin elasticity. Measurements were collected under standardized conditions at Baseline (Day 0), Week 8, Week 12, and Week 16.

Facial Skin Wrinkles

时间窗: 4 months

Visioscan measurements were taken at baseline, then at 8, 12, and 16 weeks by using a 4-grade percentage wrinkle improvement scale.

Facial Melanin Index

时间窗: 4 months

Facial pigmentation was assessed using the Mexameter, which measures melanin content via light absorption and reflection. The device reports values on a scale from 0 to 999, where higher values represent greater melanin concentration. Measurements were collected at standardized facial sites at Baseline, Week 8, Week 12, and Week 16. Higher scores indicate worse pigmentation.

Overall Facial Skin Appearance (Photo Evaluation Using SGAIS)

时间窗: 4 months

Facial skin appearance was evaluated using the Subject Global Aesthetic Improvement Scale (SGAIS), a 5-point scale where higher scores indicate greater improvement. Scores were assigned by two board-certified dermatologists who assessed photographs taken by the Visia-CR imaging system at Baseline, Week 8, Week 12, and Week 16. SGAIS scoring definition: 1 = Worse, 2 = Mild improvement (\<25%), 3 = Moderate (25-49%), 4 = Much improved (50-74%), 5 = Very much improved (≥75%).

次要结局

  • Subject Satisfaction in Improving Skin Hydration, Elasticity, Wrinkles, and Pigmentation(4 months)
  • Adverse Events(4 months)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Supawee Phanmamuang, MD

Resident of Dermatology

Institute of Dermatology, Thailand

研究点 (1)

Loading locations...

相似试验